SpringTMS Transcranial Magnetic Stimulation Device for Migraine Receives FDA Approval
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The Migraine.com team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- eNeura, Inc. Receives FDA Clearance for SpringTMS Migraine Treatment Device. Press release via Yahoo Finance. May 23, 2014. Retrieved May 23, 2014 from http://finance.yahoo.com/news/eneura-inc-receives-fda-clearance-120100623.html.
- New NICE guidance on Transcranial Magnetic Stimulation. Migraine Action. Jan. 22, 2014. Retrieved May 23, 2014 from http://www.migraine.org.uk/latest-news/new-nice-guidelines-on-transcranial-magnetic-stimulation/
- Lipton, Richard B., et al. "Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial." The Lancet Neurology 9.4 (2010): 373-380.
- Weatherall, M. W., et al. "Post market pilot programme with single pulse transcranial magnetic stimulation (sTMS) for acute treatment of migraine: SpringTMS™ use in migraine." The journal of headache and pain 14.Suppl 1 (2013): P222.